Canada must procure and maintain a stockpile of medical countermeasures (MCM), including diluent and sterile empty glass vials required for vaccination, to support response to Canadian public health emergencies and events.
The Government of Canada has a requirement for the services of a Contractor to manufacture and supply 73,500 vials of a sterile 0.2% phenol, phosphate-citrate based buffered diluent containing 45% glycerol (pH 7.4) in 2 mL labelled vials, accompanied by 11,000 empty 2mL labelled sterile glass vials with a removable cap enclosure system capable of being re-stoppered, in accordance with the technical specifications set out in Appendix A of this solicitation. The diluent and empty vials must be manufactured in accordance with Canada’s Food and Drug Regulations, Part C, Division 2 - current Good Manufacturing Practices (GMP), and be of sufficient quality for use in humans.
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.
Suppliers who have won similar work from this buyer before.
BOEHRINGER INGELHEIM ANIMAL HEALTH is the most likely incumbent, based on how often and how recently they have won this buyer’s work in this category. To displace them, expect to need a clearly stronger proposition or price.